Evidence map›Paper›PMID 29131852›Full record

ArticlePLoS pathogens2017

Unraveling the key to the resistance of canids to prion diseases.

Natalia Fernández-Borges, Beatriz Parra, Enric Vidal, Hasier Eraña, Manuel A Sánchez-Martín, Jorge de Castro, Saioa R Elezgarai, Martí Pumarola, Tomás Mayoral, Joaquín Castilla

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Identification of the Highly Polymorphic Prion Protein Gene (Animals : an open access journal from MDPI · 2025
    Article
  5. Article
  6. Article
  7. Structurally targeted mutagenesis identifies key residues supportingbioRxiv : the preprint server for biology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Intrinsic determinants of prion protein neurotoxicity inFrontiers in molecular neuroscience · 2023
    Review
  15. Probing the origin of prion protein misfolding via reconstruction of ancestral proteins.Protein science : a publication of the Protein Society · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Canine DScientific reports · 2021
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Natalia Fernández-BorgesCIC bioGUNE, Parque tecnológico de Bizkaia, Derio, Bizkaia, Spain.
Beatriz ParraLaboratorio Central de Veterinaria (LCV), Madrid, Spain.ORCID http://orcid.org/0000-0003-1169-4418
Enric VidalCentre de Recerca en Sanitat Animal (CReSA), UAB-IRTA, Campus de la Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.ORCID http://orcid.org/0000-0002-4965-3286
Hasier ErañaCIC bioGUNE, Parque tecnológico de Bizkaia, Derio, Bizkaia, Spain.ORCID http://orcid.org/0000-0001-8776-4211
Manuel A Sánchez-MartínServicio de Transgénesis, Nucleus, Universidad de Salamanca, Salamanca, Spain.
Jorge de CastroDepartment of Infectology, Scripps Florida, Jupiter, Florida, United States of America.ORCID http://orcid.org/0000-0002-2380-8956
Saioa R ElezgaraiCIC bioGUNE, Parque tecnológico de Bizkaia, Derio, Bizkaia, Spain.ORCID http://orcid.org/0000-0001-7054-9689
Martí PumarolaDepartment of Animal Medicine and Surgery, Veterinary faculty, Universitat Autònoma de Barcelona (UAB), Bellaterra (Cerdanyola del Vallès), Barcelona, Spain.
Tomás MayoralLaboratorio Central de Veterinaria (LCV), Madrid, Spain.ORCID http://orcid.org/0000-0003-2644-1966
Joaquín CastillaCIC bioGUNE, Parque tecnológico de Bizkaia, Derio, Bizkaia, Spain.ORCID http://orcid.org/0000-0002-2216-1361
CIC bioGUNE · ESUniversitat Autònoma de Barcelona · ESIkerbasque · ESScripps Institution of Oceanography · USUniversidad de Salamanca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the characteristics of prions is their ability to infect some species but not others and prion resistant species have been of special interest because of their potential in deciphering the determinants for susceptibility. Previously, we developed different in vitro and in vivo models to assess the susceptibility of species that were erroneously considered resistant to prion infection, such as members of the Leporidae and Equidae families. Here we undertake in vitro and in vivo approaches to understand the unresolved low prion susceptibility of canids. Studies based on the amino acid sequence of the canine prion protein (PrP), together with a structural analysis in silico, identified unique key amino acids whose characteristics could orchestrate its high resistance to prion disease. Cell- and brain-based PMCA studies were performed highlighting the relevance of the D163 amino acid in proneness to protein misfolding. This was also investigated by the generation of a novel transgenic mouse model carrying this substitution and these mice showed complete resistance to disease despite intracerebral challenge with three different mouse prion strains (RML, 22L and 301C) known to cause disease in wild-type mice. These findings suggest that dog D163 amino acid is primarily, if not totally, responsible for the prion resistance of canids.

Indexed as

Amino Acid SequenceAnimalsAntelopesBrainCanidaeCatsCattleChiropteraDeerDisease ResistanceDogsEncephalopathy, Bovine SpongiformMiceMice, Inbred C57BLMice, TransgenicPrion DiseasesPrPC Proteins

Identifiers

PMID29131852
PMCPMC5703577
OpenAlexW2769529271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.